GENERIC SPECIALTIES INC
ORLANDO, FLORIDA

Located in Orlando, Florida, Generic Specialties, Inc. is a dynamic player in the generic pharmaceutical arena. Established on February 11, 2014, the company excels in creating and distributing a wide array of essential medications targeting key areas like cardiovascular health, metabolic conditions, anti-infectives, and pain management. These products are available in various dosages to meet diverse patient needs. Operating as a vertically integrated enterprise, Generic Specialties combines its manufacturing prowess with strategic outsource partnerships across the globe, encompassing both U.S. facilities and international sites in India. This global network ensures a steady supply of generic drugs into the competitive U.S. prescription market. The company prides itself on being the exclusive manufacturer of hormone API's and tablets for products like Esterified Estrogen and Methyl Testosterone. Under the guidance of President Ashwin A. Mehta, Generic Specialties continues to focus on producing high-quality pharmaceuticals while navigating the complexities of healthcare regulations effectively. Their innovative 'virtual' business model allows them to harness research, development, and manufacturing efficiencies cost-effectively. They are committed to ongoing advancement in their product offerings, ensuring alignment with regulatory approvals. With a history marked by resilience, as highlighted by their recent reinstatement on December 1, 2021, the company remains dedicated to fulfilling its reporting obligations and keeping stakeholders informed, the next key report being scheduled for January 22, 2024. The headquarters located at 8007 Horse Ferry Road welcomes inquiries, while comprehensive details about their mission and services can be found on their website, genericspecialties.com.